[SaneVax: Are medical consumers in the U.S. ‘just saying no’ to HPV vaccines? A recent study indicates HPV vaccinations are being completed at a far lower rate than expected. In some age groups the completion rate in the United States dropped over 60% from 2006-09. Nevertheless, the so-called miracle cures for cervical cancer, Gardasil and Cervarix, are still being aggressively marketed to developing countries around the globe. One can only hope government health officials in these countries pay more attention to the ‘science’ behind these vaccines than marketing hype. After all, they have a duty to protect the health and safety of their population and an obligation to use precious health care money wisely.]
HPV vaccine completion rate among girls is poor, getting worse
From an article in medicalxpress.com
The proportion of insured girls and young women completing the human papillomavirus (HPV) vaccine among those who initiated the series has dropped significantly – as much as 63 percent – since the vaccine was approved in 2006, according to new research from the University of Texas Medical Branch (UTMB) in Galveston.
The study, published in the current issue of Cancer, reveals the steepest decline in vaccine completion among girls and young women aged nine to 18 – the age group that derives the greatest benefit from the vaccine, which should be administered in three doses over six months.
“The first generation of women that could benefit from the only HPV-related cancer vaccine in existence is missing the opportunity,” said lead author Abbey B. Berenson, director of the Center for Interdisciplinary Research in Women’s Health (CIRWH) at UTMB. “This vaccine prevents one of the most devastating cancers in women.”
Researchers examined a large health insurance company’s records of 271,976 female patients aged nine and older who received the first dose of the HPV vaccine between 2006 and 2009. Of this full sample, just 38.2 percent received all three doses within 365 days. In all but one age group (27 and older), researchers uncovered a marked drop in the number of females who completed the vaccine series:
HPV Vaccine Completion Rates (source: UTMB)
Age 2006 2009 Completion Dec/Inc
9-12 57.5% 21.2% – 63%
13-18 54.9% 20.8% – 62%
19-26 44.3% 22.6% – 49%
27+ 15% 24.5% + 37%